Clinical Trial Update: A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 study of Eligard (leuprolide acetate) in hormone-dependent prostate cancer completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Eligard (leuprolide acetate)

Snippet

Sponsor: Astellas Pharma Singapore Pte. Ltd. | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED | Results posted: 2020-12-09